Uncontrollable acute pain may result in prolonged hospital stay and unplanned hospital admissions and increased hospitalizations besides psychologic and physiologic e ects [4] . In a retrospective study, unplanned re-applications and admissions within postoperative 30 days was estimated as 38% [5] . Prolongation of acute pain treatment causes central and peripheric nervous system sensitization and may lead to chronic pain development of which treatment is hard and expenditure is high.
Pain was found as one of the three medical problems causing delay in discharge a er ambulatory surgery. at an e ective postoperative pain management cannot be achieved is a reality and unfortunately satisfaction is low both for the physicians and the paients. Even, in a study approximately 80% of the patients were reported to su er from pain afer surgery [6] . Many patients still su er from pain despite focusing on pain management programs and developing novel postoperative pain management programs.
Preventive Analgesia
Central sensitization and hyperexitability develop a er surgical incision and this condition results in ampli cation of postoperative pain. Some short-term (reduction in postoperative pain and acceleration of recovery) and long-term (reduction in chronic pain development) bene ts can be obtained in recovery period by preventing central sensitization through analgesic treatment. Preemptive analgesia concept is a pharmacologic strategy based on analgesic drug administration prior to surgical stimulation in order to prevent postoperative pain. Preemptive analgesia is an antinosiseptive treatment and prevents postoperative pain development by hindering a erent input formation.
e purpose is to prevent or reduce any pain memory and thereby to reduce anlgesia requirement. Main characteristics of preemptive analgesia is beginning before surgery and preventing central sensitization related to surgical trauma or in ammatory events [7] [8] [9] [10] [11] .
Multimodal Approaches
Controlling postoperative pain with unimodal approaches is almost impossible as it is a complex problem. us multimodal approach has been applied in clinical practice for last 15 years. It was determined that early mobilization, early oral intake, early returning of colon functions, early discharge and short duration of hospital stay, lower pain scores were obtained with a successful postoperative pain control and reduction in perioperative stress response was achieved with utilization of regional anesthetic techniques. Epidural anesthesia and analgesia is accepted as a complementary factor of multimodal approach due to phsiologic bene ts and near-excellent postoperative analgesia.
Treatment Methods
Many options are available for postoperative pain treatment. ese include systemic analgesics (eg, opioids, non-opioids) and regional analgesic techniques (neuroaxial and peripheral nerve blocks). Clinicians should take the prefer of the patient into consideration when evaluating individual risks and bene ts of each treatment in order to apply the best postoperative pain regimen [12] [13] [14] . at there were genetic di erences in pain susceptibility and genetic background a ecting pharmacokinetics and pharmacodynamics of analgesic drugs would be the focus of postoperative pain management in the future [15] . 
Systemic Analgesic Techniques Opioids
Opioid analgesics are one of the mainstay of postoperative pain treatment. ese agents usually acts upon µ-receptors in central and peripheric nervous sytem. A theorically important advantage of opioid analgesics is not having ceiling e ect. Use of opioid analgesics are limited due to side e ects like emesis-vomiting, sedation, respiratory depression. Opioids may be used in many formulas and in many di erent ways: subcutaneous, transcutaneous, transmucosal, intramuscular, intravenous, oral, intrathecal, epidural and intraarticular.
Opiod doses, serum concentrations and response to postoperative pain di er among individuals. For example, oral route is not prefered much in treament of moderate and severe postoperative pain as it shows a wide variability even in serum drug concentrations develops from intravenous or intramuscular route. Parenteral administrations provide faster and safer initial analgesic e ect. Duration of parenteral opioid use may prolong especially in patients who cannot tolerate oral intake in postoperative period. Switching from parenteral use to oral use of opiods begins a er the patients return to oral intake and if postoperative pain has been controlled with parenteral opiods. Continuously released oral opioids may provide a better analgesia compared to the ones when taken in case of requirement (currently paracetamole combined forms are available). Although passive form of transdermal fentanyl is not routinely used in postoperative pain treatment, a new version, patient actived electrically facilitated delivery of transdermal fentanyl is being used in hospitalized patients [16] .
Iontophoretic transdermal fentanyl
Although e ectiveness and patient satisfaction of paient controlled analgesia (PCA) have been shown, it limits intravenous administration due to risks like limitation of patient mobilization because of pump, lines and tubes and programming errors. Althogh the most widely used opioid for intravenous PCA is morphin, properties of fentanyl made it the most optimal candidate for iontrophic drug administration. Low molecular weight and high lipid solubility are among the ideal properties of a drug for transdermal administration [17] . Morphin has a lower molecular weight and higher lipophility compared to fentanyl (372 Da Fentanyl, 758 Da Morphin). Fentanyl is 100 fold stronger than morphin and passes into central nervous system 133 fold easier [18] .
Patient controlled fentanyl hydrochlorid ionotrophic tarnsdermal system (fentanyl ITS) has been designed in order to eliminate aforementioned concerns. Fentanyl ITS is an innovator, non-invasive, needle-free, self-contained, pre-programmed drug system that iontrophic method is used for transdermal fentanyl administration by applying low density electrical power in a certain area. It provides a controlled analgesia without uctuations. Conventional fentanyl patch that provides drug release in a constant velocity for 72 hours has been designed to use in chronic pain. Fentanyl ITS enables di usion of 40 µg dose into blood circulation through intact skin in 10 min. 1. hour plasma concentrations of fentanyl ITS and intravenous fentanyl are di erent (0.1 and 0.7 ng/ml, respectively).
is administration technology is much more superior to pacebo and it has been reported to be equal to patient controlled morphine analgesia [19, 20] .
In a study comparing morphine PCA and fentanyl ITS, the latter was reported to require 4% less sta (19). According to data obtained from controlled clinical trials, fentanyl ITS is a safe and e ective method in postoperative pain management. Fentanyl ITS enables reducing pain to acceptable levels following loading dose of opiods by hindering analgesia spaces and rst pass e ect develop from other pain management modalities. ereby fentanyl ITS may be a valuable option in postoperative pain management for both patients and health pro essionals that provides a safe and easy treatment and high patient satisfaction [22] .
Tramadol
Tramadol should be discussed under a separate title. Tramadol is a synthetic analogue of codeine. Its analgesic e ect is moderate. It is the only drug acts upon two di erent mechanisms. One of its metabolites has a poor a nity to μ-opioid receptor without a ecting delta and kappa receptors. e second mechanism is reuptake inhibition of neurotransmitters norepinephrin and serotonin. Tramadol causes side e ects like respiratory depression and sedation encountered with other opiods in postoperative pain treatment less. 100 mg tramadol given in peroral route at every 6 hours following hand surgey was found more e ective than metamizole and paracetamole [22] .
Tramadol /paracetamol 37.5 mg/ 325 mg oral preparations may be a bene cial option for multimodal analgesia in treatment of postoperative pain [23] . In a study comparing oral tramadol use and oral naproxen use in postoperative pain treatment a er caesarean section, both drugs were reported to have similar analgesic e ect an deven oral naproxen was reported to be preferred more by the mothers together with less side e ects [24] . Tramadol and tapentadol were reported to be approved by FDA [25] . 1-2 mg/kg intravenous tramadol was shown to be an appropriate alternative to intravenous morphin in patients who underwent tonsillectomy [26] . e most bothersome side e ects of tramadol are postoperative emesis and vomiting (9-10%), itching (7%) and rash (4%). ese side e ects' occuring during postoperative oral use is probable. Ondansetron used for treatment of postoperative emesis and vomiting was reported to lead to inhibition of tramadol analgesia due to causing reduction of binding 5-HT 3 receptors at spinal level [27] . Availability of injectable, drop and suppository forms besides preparations combined with paracetamole enables more exibility for using this drug in postoperative period. Tramadol is the best analgesic that may be used for mild and moderate postoperative pain due to its opiod sparing e ect and low incidence side e ects.
Intravenous patient-controlled analgesia
Postoperative pain frequently resulted in inadequate analgesia due to delay in administration of the analgesic agent, especially intramuscular injection when needed conventionally based on the demand of the patient.
Great changes occur in plasma drug concentration pro le develops following opioid administration via intramuscular or infusion route for postoperative pain treatment. For example; di erences reaching 2-5 fold may be observed in maximum plasma concentration of the drug during intramuscular pethidine use.
is variability leads to inadequate e ectiveness of intramuscular administrations of opioids for postoperative pain treatment. On the other hand, physicians' using analgesics by not taking drug pharmacokinetics into consideration, nurses' acting conservatively due to abstaining from side e ects that may develop during narcotic use have led to seeking safer and more e ective methods for postoperative analgesia.
PCA is a closed circuit conrol system that the individual plays an active role in pain control. e method is based on an infusion technique that a special pump is used and a preconditioned analgesic drug is used in a speci ed way, by patient's pressing a button and that may be programmed in many di erent ways and doses. A timer in the However user and operator related errors are frequently seen besides material and equipment related faults [28, 29] . In conclusion, intravenous PCA provides a superior anlagesia and a good patient satisfaction compared to conventional PRN analgesia regimen. Recommended opiods, doses and programs are given in Table 1 .
Nonsteroidal antiin ammatory drugs
Nonsteroidal antiin ammatory drugs are still super uous popular drugs.
ey have a wide use area in musculosceletal and chronic pain. Showing local e ect without causing side e ects and cognitive disturbances are the advantages of these drugs. Although their side e ects have been de ned well some side e ects were neglected and underestimated. Opiophobia of both physicians and the patients, commercial concerns of drug companies make NSAIDs remain still popular.
ey are composed of a heterogenous group with di erent chemical structures, pharmacologic and therapeutic e ects. ese group of drugs are also called as peripherally e ective drugs as they develop analgesia with e ects on peripheral regions that the pain arises. ese agents that have varying degrees of analgesic, antipyretic and antiin ammatory e ects do not lead to addiction and tolerance di erently from opioids.
is group of drugs are used either alone in mild or moderate pain or in treatment of severe postoperative pain together with adjuvants or in combination with opioids ( Table 2 ).
NSAIDs that are also called as nonopioid analgesics show their analgesic and antiin ammatory e ects by inhibiting prostaglandin synthesis as the result of cyclooxygenase enzyme inhibition. Cyclooxygenase has two forms named as cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) . Most of NSAIDs inhibit COX-1 and COX-2 isoform in a non-selective way or have a small degree of selectivity for COX-1. ey consequently block in ammatory cascade and cyclooxygenase by inhibiting prostaglandin and tromboxane and lead to reduction in pain, fever, platelet aggregation and in ammatory response [30] . On the other hand, some novel antiin ammatory drugs like nabumeton and meloxicam speci cly inhibit COX-2. Ulcerogenic side e ect incidence of COX-2 selective NSAIDs are lower.
Acetaminophen and other antipyretics e ect as reducing pain and fever with primary central mechanism. Acetaminophen is antipyretic and analgesic however has a very little anitin ammatory e ect. Its analgesic e ect is no more than conventional analgesics and has less side e ects. Its mechanism of action was discussed and it was seen to cause COX-3 inhibition. Intravenous form of acetaminophen was produced and begun to use in recent years. 10 mg/mL paracetamol in 100 ml solution is used as infusion in 15 min or longer. Its e ect begins within 5-20 min, reaches peak level in 1-2 hours and its duration of e ect is 4-6 hours. IV paracetamol is the pro-drug of acetaminophen. Analgesic e ect of paracetamol is accepted to be related with blood concentration of the drug. 1 gr of IV paracetamol is hydrolized to 0.5 gram acetaminophen and thus 15 mg/kg of acetaminophen is equal to 30 mg/kg of paracetamol. Recomended dose is 15 mg/ kg. It cannot control moderate and severe postoperative pain alone however decreases opioid requirement 40-50% in its combination with NSAIDs [31-33]. Intravenous acetaminophen should be considered to use in mild or moderate postoperative pain [34, 35] . Primary goal of developing selective COX-2 inhibitors (Coxibs) is to reduce gastrointestinal bleeding and risks. Coxibs may be an interesting option in management of postoperative pain. is explains why they should be theorically discriminated from conventional NSAIDs due to their less harmful e ect on platelet functions and hemostasis. An opinion about generalization of Coxib use can be made only a er determination of risk-bene t ratios of all NSAIDs. Whether Coxibs have speci c properties in certain conditions should be determined through studies. However their increased costs are more than their bene ts. ey were reported to be able to be a part of multimodal approach in management of postoperative pain [36-38].
Analgesic adjuvants
Dexmedetomidine: Dexmedetomidine is a highly selective α2 adrenergic agonist. It has 8 fold greater receptor a nity compared to clonidine. It extremely reduces analgesic and anesthetic requirement due to their analgesic properties and increasing the e ect of local anesthetics by changing ion transport and membrane potential in
Bolus
Continuous rate TRPV receptors are activated as the result of highly intensive stimuli and substance P is released. Constant release of substance P leads to capsaicin depletion in presence of capsaicin and a erwards it leads to reduction of pain by decreasing C ber activation. Capsaicin does not have a signi cant e ect on A delta and A alpha bers. It also does not a ect sense of hot and touch.
All doses are for adult patients
Both topical and injectable forms of capsaicin are used in management of postoperative pain, arthritis, musculosceletal pain and neuropathic pain. Capsaicin cream is usually combined with opioid and NSAID and thereby it may be used in painful conditions lke low back pain, cervical pain, many forms of arthritis, muscle spasms and ligament stretching. ey may be used in high concentrations in postherpetic neuralgia and may hinder respiratory depression e ect caused by opioid use in the elderly by bene ting from opioid sparing e ect [44] . e most important side e ect is severe burning in application area and degree of burning is directly proportipnal with drug concentration.
Ketamine: NMDA receptor is a glutamate receptor characterized with N-methyl-D-aspartate a nity. Excitation of NMDA receptor in dorsal root plays an important role in sensitization process [45] . Recently, NMDA receptors were shown to be located in periphery of unmyelinated axons and thus excitator aminoacids could play a role in primary nosiseption in periphery in addition to their roles in central nervous system. Use of ketamine in treatment of pain was mentioned in publications in 1996 [46] . It is the best anesthetic known for 30 years and it was shown to have an interaction with many receptor systems like NMDA receptor system, opioid, monoaminergic receptor and muscarinic receptor [47, 48] . It may lead to selective non-competative NMDA blockadge in subanesthetic doses. In some studies carried out with low dose ketamine, it was shown to be e ective in postoperative analgesia. Vast majority of the studies are focused on use of ketamine as an preemptive analgesic [11] and some studies suggest its postoperative use [49] .
Ketamin is reported to cause psychomimetic side e ects in postoperative period even with low doses [11] . Ketamine may be developed in various surgical procedures and anesthesia techniques by using intraoperatively and postoperatively for postoperative pain treatment. It may be used to reduce postoperative pain especially in intraoperative subanesthetic dose under general anesthesia.
Gabapentin:
Gabapentin was initially an antiepileptic drug and a structural analogue of gamma-aminobutyricacid (GABA). It binds to α2-δ protein subunit of voltage-dependent calcium channels that are widely available in central and peripheral nervous system. is inhibits in ux of calcium and decreases excitator neurotarnsmitter release in pain pathways [50] .
Analgesic e ect of gabapentin was widely investigated in surgical environments. As the result of these studies, it was reported to have an analgesic e ect in postoperative pain [51] [52] [53] [54] .
Pregabalin: Pregabalin is a lipophilic GABA analogue that has analgesic, anticonvulsant, anxiolytic, sleep modulation and opioid sparing e ects. It was stated to be e ective in many neuropathic pain models [55, 56] , incisional injury [57] and in ammatory conditions [59] as the successor of gabapentin. Pregabalin used in varying degrees of neuropathic pain like postherpetic neuralgia, painful diabetic neuropathy, central neuropathic pain and bromyalgia. In the studies in recent years, there is an increasing interest that it is a part of multimodal analgesia in pain control. It is quite helpful in controlling postoperative pain through its opioid sparing and sedative e ects although it was shown to have a signi cant analgesic e ectiveness in acute conditions [59] . Although its mechanism is similar to gabapentin its pharmacologic pro le is more superior.
Its reducing opioid requirement, preventing and decreasing opioid tolerence, increasing the quality of opioid analgesia, reducing respiratory depression, improving anxiety and gastric sparing e ects make this agent attractive for management of postoperative pain.
Tapentadol: Tapentadol acts via central way with norepinephrin reutake inhibition and µ receptor agonist e ect [60] [61] [62] . In humans, while it has 18 fold greater a nity to µ opioid receptors, it is 2-3 fold less e ective than morphin. It was developed as the result of tolerance lowering studies . tapentadol is a novel analgesic with central e ect and side e ect incidence is lower than opioids. It was initially formulated as immediate-release preparation. Tapentadol was approved as potent Schedule II analgesic by US Food and Drug Administration (FDA). It is also the rst analgesic developed in recent 25 yars for management of moderate and severe pain [63] .
Tapentadol has two di erent forms.
e rst is immediate release 50, 75 and 100 mg tablets and it provides analgesia for 4-6 hours. Tapentadol was accepted to have equal analgesic potency with hydrocodone and oxycodone between tramadol and morphin. Tapentadol was seen to provide similar analgesic e ectiveness compared to immediate release oxycodone [61] . It was also reported to be as e ective as oxycodone in patients su ering from osteoartritrelated and chronic low back pain [64] . Its analgesic e ect was shown in in ammatory, somatic and neuropathic pain and it was shown to have a better gastrointestinal tolerability (in terms of emesis, vomiting, constipation) compared to opioids [65] . e second form, tapentadol extended release (ER) is a constantly released form that may be e ective for 12 hours for patients 18 years and above su ering from moderate and severe pain. It is used twice a day. Beginning of tolerance is low in chronic use and it signi cantly delays beginning of tolerence compared to morphin [66] . Its use is contrandicated in patients with severe bronchial asthma, paralytic ileus and using monoamine oxidase inhibitors.
Regional Analgesic Techniques
Neuroaxial and peripheric analgesic techniques may be used for e ective treatment of pain. Analgesia provided by epidural and peripheric analgesic techniques is superior to systemic opioids [67] and morbidity and mortality decrease as the result of using these techniques [68, 69] . Still, these techniques have some risks and the clinicans determine the appropriateness of neuroaxial and peripheric regional techniques by evaluating the individual risks and bene ts of them.
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Post Operative Anesthesia
Single dose neuroaxial opioids
Opiods are administered intrathecally or epidurally as single agent or adjvant. One of the most important factors for determination of clinical pharmacology of any opioid is the degree of lipophility or hydophility. Hyrdophilic opioids like morphin tend to stay in cerebrospinal uid when they reached cerebrospinal uid once through gradual migration from epidural space or directly intrathecal injection. e e ect begins late and takes long. Ratio of side e ects is high due to supraspnal and cephalic invasion.
Neuroaxial application of lipophilic opioids like fentanyl limits formation of some side e ects like delayed respiratory depression due to rapid onset of analgesia and clearance from CSF. When studies reporting that there is not a di erence between intravenous or epidural use of lipophilic agents in terms of dose and e ect are taken into consideration, the most appropriate agent for single use seems to be morphin among opioids administered via neuroaxial route for postoperative analgesia. In the study carried out in 17 European countries, the most commonly preferred agents were seen to be morphin and fentanyl (Table 3) [70].
Concentration of fentanyl in systemic circulation rapidly increases a er given into epidural space as it is a highly lipophilic opioid and it may reach systemic analgesic doses. Sometimes arguments occured that highly lipophilic opioids did not have a di erence between systemic or epidural e ciency in terms of analgesia. However epidural fentanyl was shown to have an analgesic e ect even when the amount of epidural fentanyl in systemic circulation is below analgesic level [71] . Required dose of intravenous fentanyl for analgesia in the same time and quality is 2-3 fold of epidural fentanyl dose. Blood level may reach sstemic analgesic dose when infusion is made. It shows a rapid analgesic e ectiveness in intrathecal injection due to its rapid transport to arterial circulation and rapid di usion to medulla spinalis and receptor a nity. e most commonly used opioid for epidural analgesia is morphin. Quality of analgesia in postoperative period was found superior to systemic application in many studies. It was observed to show analgesic e ciency even in very low blood concentrations a er epidural injection [72] . Intravenous morphin dose required for analgesia for the same time and quality is approximately 10 fold greater than epidural morphin dose. It accumulates in CSF due to its highly hydrophility and it shows a wide dermatomal invasion. Low doses should be initiated in the elderly patients and in epidural injections made from high levels like thracal cervical. Morphin concentration in CSF a er intrathecal morphin injection is very high. It slowly passes from CSF towards opioid receptors in medulla spinalis due to its low lipid solubility. 0.1-0.3 mg is su cient for postopertaive analgesia.
Epidural or intrathecal opioids may be given as intermittent injections and constant infusion. Ideal way for administration of morphin is intermittent injections as neuroaxial use of morphin may provide analgesia for long periods that may exceed even 24 hours. Duration of e ect is shorter for agents with high lipid solubility and it may require frequent injections.
us continuous infusion technique may provide an advantage with providing continuous analgesia and ease of application. However technologic need is more in this way. It may be remembered that side e ect incidence due to drug accumulation may increase and the lowest possible doses should be used in continuous infusion techniques. Nurses' monitoring the patients being well educated is also an important factor for choosing the technique.
Extended Release Epidural Morphine (EREM)
is new drug that may be applied as a single dose seems close to our analgesic targets. A duration of e ect that may prolong to 48 hours may be seen when EREM is used [73] [74] [75] [76] [77] . Side e ects may also be avoided in case of opioids' cannot reach systemic concentrations besides better patient activity.
EREM was formulated so as to be administered epidurally at lumbar level. It was shown in a few studies to provide long lasting analgesia.
Side e ects of EREM was treated with opioid antagonists. Opioid antagonists were needed in 10-12.5% of EREM administered patients [73] [74] [75] [76] [77] [78] . Elderly are susceptible to the e ect of EREM and close perioperative monitorization is required. 15 mg applied to the elderly patients and 20 mg EREM applied to the young patients were shown to be equal [78] . A careful perioperative monitorization is required for the elderly patients.
Patient controlled epidural analgesia
Intravenous patient controlled analgesia is a frequently used analgesia technique that is widely accepted. Epidural use of it may provide some bene ts like reducing dependence on health personnel, determining minimal e ective dose easier and individually. However these advantages may also lead to potential risks. Possible risks due to the patient's using more than needed opioid or local anesthetic are some of them. ey do not have accepted ideal bolus or infusion doses, deadlock time. Highy lipophilic agents may be used in bolus mode due to short time for beginning of the e ect. In case of using opioid local anesthetic combinations, it may be considered to give one of the agents as continuous infusion and the other as patient controlled boluses. Our patient controlled analgesia methods are presented in the table (Table 4) . like hematoma and epidural abscess. is procedure had obvious bene ts for the patients and adverse events developed minimally were shown in many randomized studies [79] . Commonly used continuous peripheric nerve block analgesia regimens are shown in Table 5 . In clinical trials including these analgesia regimens, it was stated that continuous peripheric nerve blocks were as e ective as continuous epidural block following orthopedic surgery concerning lower and upper extremities. Both blocks were found much more e ective than intravenous opioids [79] . Additionally, regional analgesia needs to be used in critically ill patients in order to reduce sedative and opioid drug use.
Continuous peripheric nerve block

Chronicity of postoperative pain
Chronic pain developing following surgery was a condition that was not taken into account. However in recent years, it has begun to explicated signi cantly as a clinical and even a social roblem. Because postoperative chronic pain was detected to be seen not only a er major surgery but also a er minor surgery like inguinal hernia and vasectomy. Incidence of postoperative chronic pain was estimated as 1.8-6.7% in USA and 0.5-14% in Great Britain. Young age, presence of preoperative pain, malignity, infection, repeated surgical operations, type and duration of surgery, incision site, experience of the surgeon and genetic predisposition form preoperative risk factors [80, 81] . Intraoperative nerve ınjury, complex surgical approaches or severe pain that was not treated in postoperative period, radiotherapy and chemotherapy, anxiety, depression form intraoperative and postoperative predictive factors.
All surgical procedures occur a er an incision. Pain does not become chronic a er every incision. In a study, it was adduced that more than half of acute postoperative neuropathic pain would convert to chronic neuropathic pain [82] . However conditions like intercostal nerve injury during thoracotomy, nerve injuries developing a er traction, positioning or direct trauma in orthopedic operations or brachial plexus injury in axillary dissection in breast surgery are not rare and ratio of chronicity of the pain is high in these conditions (Table 6) According to many studies about chronic pain, postoperative pain was shown to be treated inadequately in acute period. ese include conditions like breast surgery, hernia repair and thoracotomy [84] [85] [86] . e most important dilemma is probably about drugs and methods. Preemptive drugs are known to limit and better control acute postoperative pain. However epidural anesthesia applied during the surgery is known to prevent central sensitization and thus is a very important method that may prevent chronicity of postoperative pain.
In conclusion, di erent opinions should be put forward about this issue.
Chronic pain that has become a signi cant public health problem as it a ects many people brings severe economic outcomes together besides signi cantly a ecting quality of life.
Conclusion
Acute postoperative pain is a clinical condition that should be treated accurately and completely. Each patient should be evaluated individually in preoperative period and the method should be determined according to the severity of the pain. is method should be a noninvasive method that may control postoperative pain. Management of postoperative pain, a very di cult process, should begin in preoperative period, multimodal approach formed by newly developed drugs and regional techniques, preemptive analgesia methods may convert the di cult to easy. So we may also join to 'Hospitals Without Pain' of SIAARTI Study Group[87]. 
